;

3.00 USD

Opening hours: 09:30 - 16:00 (Eastern Standard Time: 12/24/2024 8:31:33 AM)
Exchange closed, opens in 58 minutes
-5.48 USD (-5.48%)
-7.17 USD (-7.17%)
-15.38 USD (-15.38%)
-37.14 USD (-37.14%)
-51.11 USD (-51.11%)
-97.95 USD (-97.95%)
-55.56 USD (-55.56%)
-98.10 USD (-98.10%)

About Amarin Corp PLC

Market Capitalization 189.22M

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Headquarters (address)

Iconic Offices, The Greenway

Dublin 112-114

Ireland

Phone353 0 166 99020
Websitehttps://www.amarincorp.com
Employees275
SectorHealthcare
IndustryDrug Manufacturers General
TickerAMRN
ExchangeNASDAQ Stock Exchange
CurrencyUSD
52 week range3.00 - 1.37
Market Capitalization189.22M
P/E trailing-3.07
P/E forward-2.19
Price/Sale3.00
Price/Book3.00
Beta1.93
EPS3.00
EPS Ireland (ID:161, base:52) 2.88

CleverShares.com|
2024 ©

1.0.9119.29486